News
PRE
16.16
+1.83%
0.29
Prenetics updates financial calendar ahead of Q1 2026 results release, earnings call
PUBT · 2d ago
Prenetics’ IM8 Secures Equity-Linked Multi-Year Supplement Partnership With Inter Miami CF
TipRanks · 3d ago
Prenetics IM8 becomes Inter Miami CF exclusive health supplements partner in multiyear deal
PUBT · 3d ago
PRENETICS’ IM8 NAMED EXCLUSIVE HEALTH SUPPLEMENTS PARTNER OF INTER MIAMI CF IN MULTI-YEAR PARTNERSHIP
Reuters · 4d ago
Prenetics to Exit Bitcoin Holdings and Reinvest Up to $40 Million in Core IM8 Health Business
TipRanks · 6d ago
Prenetics plans exit from Bitcoin, shifts capital allocation to IM8 growth
PUBT · 6d ago
Weekly Report: what happened at PRE last week (0427-0501)?
Weekly Report · 05/04 10:19
Prenetics FY25 net loss narrows 19.73% to $39.98 million; revenue jumps to $92.39 million
PUBT · 04/30 14:21
Press Release: First Horizon Declares Cash Dividends on Common and Preferred Stock
Dow Jones · 04/28 20:15
Weekly Report: what happened at PRE last week (0420-0424)?
Weekly Report · 04/27 10:22
Prenetics Global: Quarterly Subscription Focus Could Turn $120M AAR Into A Billion-Dollar Machine
Seeking Alpha · 04/24 11:23
Weekly Report: what happened at PRE last week (0413-0417)?
Weekly Report · 04/20 10:18
Prenetics Global: On Course To Hit Profitability Amid Globalization Drive
Seeking Alpha · 04/18 15:08
Weekly Report: what happened at PRE last week (0406-0410)?
Weekly Report · 04/13 10:22
Weekly Report: what happened at PRE last week (0330-0403)?
Weekly Report · 04/06 10:22
Prenetics Brings Giannis Antetokounmpo Onboard as IM8 Global Partner and Shareholder
TipRanks · 04/02 13:56
Prenetics sees IM8 2026 revenue about $180 million-$200 million
Reuters · 04/02 13:06
Prenetics files to sell 2.36M Class A ordinary shares for holders
TipRanks · 03/31 13:31
BRIEF-Prenetics Global Ltd Files For Offering Of Up To 2.36 Million Class A Ordinary Shares By Selling Shareholders - SEC Filing
Reuters · 03/31 13:26
Prenetics Global files initial beneficial ownership statement for director Darshan Ravindra Shah
Reuters · 03/30 10:36
More
Webull provides a variety of real-time PRE stock news. You can receive the latest news about Prenetics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRE
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.